ATYR Q4 2025 Earnings — aTyr Pharma, Inc. Revenue & Financial Results | Market Cap Arena

ATYRaTyr Pharma, Inc.

$93M

Q4 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$394,000

Operating Income

-$15M

Net Income

-$14M

EPS (Diluted)

$-0.14

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$12M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$93M

Total Liabilities

$27M

Stockholders' Equity

$67M

Cash & Equivalents

$11M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$394,000	-$12M	+96.8%
Operating Income	-$15M	-$16M	+6.5%
Net Income	-$14M	-$15M	+6.7%